Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
The diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increas...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/4/1520 |
id |
doaj-058274f6313e4bea9e05c70e0de16bf4 |
---|---|
record_format |
Article |
spelling |
doaj-058274f6313e4bea9e05c70e0de16bf42020-11-25T01:40:48ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-02-01214152010.3390/ijms21041520ijms21041520Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced DysfunctionShujin Wang0Li-Yen Wong1Dietbert Neumann2Yilin Liu3Aomin Sun4Gudrun Antoons5Agnieszka Strzelecka6Jan F.C. Glatz7Miranda Nabben8Joost J.F.P. Luiken9Department of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartments of Pathology, CARIM School for Cardiovascular Diseases, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartments of Physiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsThe diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increased lipid uptake. We previously showed that endosomal retention of CD36 is dependent on the proper functioning of vacuolar H<sup>+</sup>-ATPase (v-ATPase). Excess lipids trigger CD36 translocation through inhibition of v-ATPase function. Conversely, in yeast, glucose availability is known to enhance v-ATPase function, allowing us to hypothesize that glucose availability, via v-ATPase, may internalize CD36 and restore contractile function in lipid-overloaded cardiomyocytes. Increased glucose availability was achieved through (a) high glucose (25 mM) addition to the culture medium or (b) adenoviral overexpression of protein kinase-D1 (a kinase mediating GLUT4 translocation). In HL-1 cardiomyocytes, adult rat and human cardiomyocytes cultured under high-lipid conditions, each treatment stimulated v-ATPase re-assembly, endosomal acidification, endosomal CD36 retention and prevented myocellular lipid accumulation. Additionally, these treatments preserved insulin-stimulated GLUT4 translocation and glucose uptake as well as contractile force. The present findings reveal v-ATPase functions as a key regulator of cardiomyocyte substrate preference and as a novel potential treatment approach for the diabetic heart.https://www.mdpi.com/1422-0067/21/4/1520vacuolar h<sup>+</sup>-atpaselipid accumulationinsulin resistancecontractile functiondiabetic heart |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shujin Wang Li-Yen Wong Dietbert Neumann Yilin Liu Aomin Sun Gudrun Antoons Agnieszka Strzelecka Jan F.C. Glatz Miranda Nabben Joost J.F.P. Luiken |
spellingShingle |
Shujin Wang Li-Yen Wong Dietbert Neumann Yilin Liu Aomin Sun Gudrun Antoons Agnieszka Strzelecka Jan F.C. Glatz Miranda Nabben Joost J.F.P. Luiken Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction International Journal of Molecular Sciences vacuolar h<sup>+</sup>-atpase lipid accumulation insulin resistance contractile function diabetic heart |
author_facet |
Shujin Wang Li-Yen Wong Dietbert Neumann Yilin Liu Aomin Sun Gudrun Antoons Agnieszka Strzelecka Jan F.C. Glatz Miranda Nabben Joost J.F.P. Luiken |
author_sort |
Shujin Wang |
title |
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction |
title_short |
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction |
title_full |
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction |
title_fullStr |
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction |
title_full_unstemmed |
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction |
title_sort |
augmenting vacuolar h<sup>+</sup>-atpase function prevents cardiomyocytes from lipid-overload induced dysfunction |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2020-02-01 |
description |
The diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increased lipid uptake. We previously showed that endosomal retention of CD36 is dependent on the proper functioning of vacuolar H<sup>+</sup>-ATPase (v-ATPase). Excess lipids trigger CD36 translocation through inhibition of v-ATPase function. Conversely, in yeast, glucose availability is known to enhance v-ATPase function, allowing us to hypothesize that glucose availability, via v-ATPase, may internalize CD36 and restore contractile function in lipid-overloaded cardiomyocytes. Increased glucose availability was achieved through (a) high glucose (25 mM) addition to the culture medium or (b) adenoviral overexpression of protein kinase-D1 (a kinase mediating GLUT4 translocation). In HL-1 cardiomyocytes, adult rat and human cardiomyocytes cultured under high-lipid conditions, each treatment stimulated v-ATPase re-assembly, endosomal acidification, endosomal CD36 retention and prevented myocellular lipid accumulation. Additionally, these treatments preserved insulin-stimulated GLUT4 translocation and glucose uptake as well as contractile force. The present findings reveal v-ATPase functions as a key regulator of cardiomyocyte substrate preference and as a novel potential treatment approach for the diabetic heart. |
topic |
vacuolar h<sup>+</sup>-atpase lipid accumulation insulin resistance contractile function diabetic heart |
url |
https://www.mdpi.com/1422-0067/21/4/1520 |
work_keys_str_mv |
AT shujinwang augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT liyenwong augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT dietbertneumann augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT yilinliu augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT aominsun augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT gudrunantoons augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT agnieszkastrzelecka augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT janfcglatz augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT mirandanabben augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction AT joostjfpluiken augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction |
_version_ |
1725043507800834048 |